Drug and Therapeutics Bulletin 1997;35:49-52; doi:10.1136/dtb.1997.35749
Copyright © 1997 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Drug-induced agranulocytosis

Drug-induced agranulocytosis is a rare, potentially fatal idiosyncratic reaction that can occur unpredictably with a wide variety of drugs when taken in a conventional dose. In this article, we discuss its diagnosis and management and we consider the drugs most commonly involved and ways of minimising risk. We do not consider the dose-related granulocytopenia that commonly complicates treatment with cytotoxic and other myelosuppressant drugs, nor the rarer reaction, aplastic anaemia.

This article has been cited by other articles:

				W S A Smellie, J Forth, S Sundar, E Kalu, C A M McNulty, E Sherriff, I D Watson, C Croucher, T M Reynolds, and P J Carey Best practice in primary care pathology: review 4 J. Clin. Pathol., September 1, 2006; 59(9): 893 - 902. [Abstract] [Full Text] [PDF]

				F W F Hanna, J H Lazarus, and M F Scanlon Fortnightly review: Controversial aspects of thyroid disease BMJ, October 2, 1999; 319(7214): 894 - 899. [Full Text]

				ELABORATION: Drug-induced agranulocytosis - monitoring antithyroid treatment DTB, November 1, 1997; 35(11): 88 - 88. [Full Text] [PDF]